+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Breast Biopsy Market by Technology, Procedure Type, End User - Global Forecast to 2030- Product Image
Breast Biopsy Market by Technology, Procedure Type, End User - Global Forecast to 2030- Product Image
Sale

Breast Biopsy Market by Technology, Procedure Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083426
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Breast Biopsy Market grew from USD 1.09 billion in 2024 to USD 1.20 billion in 2025. It is expected to continue growing at a CAGR of 9.31%, reaching USD 1.87 billion by 2030.

Shaping the Future of Breast Biopsy with Comprehensive Insights

Breast biopsy remains a cornerstone of diagnostic medicine, evolving in tandem with technological innovation and clinical best practices. Over recent years, the intersection of imaging modalities, device miniaturization, and precision guidance has transformed how physicians approach tissue sampling in breast pathology. As patient expectations for comfort and accuracy intensify, the industry is tasked with delivering solutions that minimize invasiveness without compromising diagnostic yield. This introduction provides an overarching view of the current state of breast biopsy, highlighting the drivers behind increased adoption of advanced techniques, from core needle approaches to vacuum-assisted systems.

Leading research bodies and clinical associations now emphasize the importance of real-time imaging feedback and automated sampling to reduce repeat procedures and streamline workflows. Simultaneously, healthcare providers are under pressure to balance cost containment with outcome superiority. By framing the discussion around these dual imperatives, the following analysis contextualizes the market’s underlying forces and sets the stage for a deeper exploration of transformative shifts, regulatory headwinds, and segment-specific opportunities.

Paradigm Shifts Redefining Breast Biopsy Practices

Innovation rarely follows a linear path, and the breast biopsy landscape exemplifies this truth. In the last five years, stress on non-invasive diagnostics and patient comfort spurred a surge in refined ultrasound-guided techniques, while progress in MRI guidance expanded access to lesions invisible to conventional imaging. Concurrently, developers have introduced hand-held vacuum-assisted platforms that bring high-precision sampling out of traditional radiology suites, empowering smaller centers to perform complex procedures on site.

Further compounding these shifts, artificial intelligence and advanced visualization algorithms now support real-time lesion characterization, guiding needle positioning down to a millimeter. This leap forward has not only enhanced accuracy but also fostered greater confidence among clinicians, prompting broader acceptance of stereotactic and palpation-guided modalities. Such advances underscore a fundamental transformation: breast biopsy is no longer confined to a narrow set of tools but is expanding into a versatile, multi-modal intervention that adapts to both lesion type and clinical setting.

United States Tariffs 2025 and Their Cumulative Impact on Breast Biopsy Industry

The implementation of new tariff measures in the United States for 2025 introduces a complex variable into the breast biopsy equipment supply chain. Import duties on certain medical device components are poised to increase production costs, prompting manufacturers to reevaluate sourcing strategies and pass-through pricing. Hospitals and outpatient centers may face higher expenditures for core needle devices, vacuum-assisted platforms, and ultrasound probes, affecting capital budgeting and procurement cycles.

Cumulatively, these tariffs could lead to a realignment of purchasing patterns, with domestic production gaining favor where local capacity exists. Conversely, reliance on imported echo-enhanced needles or table-configured vacuum units may diminish unless mitigating agreements are reached. Beyond direct cost implications, the regulatory environment is likely to influence competitive positioning, incentivizing strategic partnerships between device makers and local assemblers. Stakeholders must anticipate these shifts to preserve operational margins and ensure continuous access to critical biopsy technologies.

Deep Dive into Breast Biopsy Market Segmentation and Emerging Trends

A granular understanding of market segmentation illuminates avenues for targeted growth and resource allocation. Examining technology strata reveals that core needle biopsy devices command a substantial share, with automated systems onto which semi-automated variants are layered, offering diverse cost-performance balances. Fine needle aspiration continues to serve specific cytological needs, with echo-enhanced needles emerging as a premium option alongside standard variants. Vacuum-assisted systems are differentiated by form factor, where handheld models cater to ambulatory settings and table-configured units support higher-volume radiology departments.

Procedure type segmentation further refines opportunity mapping. MRI-guided approaches split between closed and open bore designs, each optimized for lesion visibility and patient comfort. Palpation methods range from freehand to grid-guided frameworks, facilitating rapid sampling in low-resource environments. Stereotactic techniques, whether prone or upright, address complex lesion geometry, while ultrasound guidance extends from basic two-dimensional imaging to advanced three-dimensional reconstructions that empower more precise targeting.

End-user segmentation highlights the varied environments in which biopsy solutions must perform. Ambulatory surgery centers, including specialized diagnostic or outpatient surgery venues, demand streamlined workflows and compact instrumentation. Hospitals, both private and public, balance high case volumes with stringent regulatory oversight. Specialty clinics, notably oncology and radiology practices, prioritize devices that integrate seamlessly into broader cancer care pathways, emphasizing ergonomics and multiprocedural efficiency.

Geographic Trends Illuminating Regional Breast Biopsy Dynamics

Regional dynamics shape the trajectory of breast biopsy adoption and innovation across distinct healthcare ecosystems. In the Americas, established reimbursement frameworks and advanced infrastructure have accelerated the integration of vacuum-assisted and MRI-guided techniques, with leading centers pioneering next-generation workflow optimization. Europe, the Middle East & Africa present a more heterogeneous picture, where high-income nations adopt precision imaging rapidly while emerging markets prioritize cost-effective palpation and ultrasound-guided methods tailored to varying resource levels.

The Asia-Pacific region stands out for its dual momentum: robust government-led screening programs in China and Japan drive demand for state-of-the-art biopsy devices, while India’s growing outpatient surgery networks increasingly adopt portable core needle and fine needle aspiration platforms. Across all regions, cross-border collaborations and technology transfer agreements are fostering a more unified global standard of care, ensuring that advancements in accuracy, safety, and patient comfort permeate diverse clinical settings.

Competitive Landscape Reveals Key Players Driving Innovation

The competitive arena in breast biopsy is defined by a handful of influential players championing innovation through strategic investments and partnerships. Leading medical device manufacturers have accelerated product pipelines, introducing fully integrated imaging-device suites and next-generation vacuum-assisted platforms that reduce tissue trauma. Collaborative research agreements between device companies and academic centers drive clinical validation, accelerating regulatory approvals and bolstering market credibility.

Simultaneously, nimble start-ups leverage novel materials and miniaturization techniques to challenge established portfolios, often focusing on niche applications such as microcoring needles or AI-driven lesion detection software. In response, legacy firms bolster their offerings via selective acquisitions and technology licensing, aiming to deliver end-to-end solutions that span screening, diagnosis, and post-biopsy analytics. The resulting landscape is both collaborative and competitive, with partnerships forming around shared goals of enhancing accuracy and procedural efficiency.

Actionable Strategies for Leaders to Capitalize on Market Opportunities

Industry leaders should prioritize the development of hybrid imaging-device platforms that seamlessly integrate ultrasound, MRI, and stereotactic guidance to meet the evolving demands of multidisciplinary care teams. Targeted investment in automated core needle and echo-enhanced fine needle technologies will differentiate portfolios, improving sampling precision and reducing the need for repeat procedures. In parallel, fostering relationships with payers and policy makers can unlock favorable reimbursement pathways, particularly for advanced vacuum-assisted and AI-supported biopsy solutions.

Expanding presence in high-growth regions through strategic alliances or local manufacturing partnerships will mitigate tariff exposure and strengthen supply chain resilience. Moreover, implementing robust training programs and digital support tools for clinicians can accelerate adoption curves and cement long-term loyalty. By embracing a holistic strategy that balances product innovation with market access initiatives, companies can harness lucrative segment opportunities and secure leadership in this dynamic field.

Rigorous Research Methodology Ensuring Data Integrity

This analysis is underpinned by a rigorous multi-stage research framework combining primary and secondary data sources. Primary insights were obtained through structured interviews with leading oncologists, radiologists, and procurement executives across major healthcare systems, supplemented by quantitative surveys targeting device utilization and procedural preferences. Secondary research encompassed a thorough review of regulatory filings, peer-reviewed literature, patent databases, and industry white papers to map technological developments and competitive activity.

Data validation was achieved through triangulation, contrasting real-world adoption metrics with vendor-reported shipment figures and published clinical outcomes. An advisory panel of subject-matter experts provided iterative feedback, ensuring that segmentation hierarchies and regional analyses accurately reflect market realities. This methodological rigor guarantees that the findings presented here are both robust and actionable for stakeholders seeking evidence-backed guidance.

Concluding Perspectives on Breast Biopsy Market Evolution

In summary, the breast biopsy market is at a pivotal juncture, driven by converging forces of technological innovation, regulatory shifts, and evolving clinical preferences. As import tariffs reshape supply chains, segmentation insights across technology, procedure type, and end-user channels reveal distinct avenues for growth and differentiation. Geographic analyses underscore the necessity of region-specific strategies, while the competitive landscape highlights the importance of collaboration and rapid product development.

For industry participants, the imperative is clear: adapt swiftly to external headwinds, invest strategically in high-precision platforms, and engage deeply with both payers and clinicians to streamline adoption. By doing so, organizations will not only meet current diagnostic demands but also anticipate future clinical paradigms, securing a leadership position in an increasingly sophisticated breast biopsy ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Core Needle Biopsy Devices
      • Automated Core Needle Biopsy Devices
      • Semi-Automated Core Needle Biopsy Devices
    • Fine Needle Aspiration Needles
      • Echo Enhanced FNA Needles
      • Standard FNA Needles
    • Vacuum-Assisted Systems
      • Handheld Vacuum-Assisted
      • Table Configured Vacuum-Assisted
  • Procedure Type
    • MRI Guided
      • Closed Bore
      • Open Bore
    • Palpation Guided
      • Freehand Palpation
      • Grid Guided
    • Stereotactic
      • Prone Stereotactic
      • Upright Stereotactic
    • Ultrasound Guided
      • 2D Ultrasound Guided
      • 3D Ultrasound Guided
  • End User
    • Ambulatory Surgery Centers
      • Diagnostic Centers
      • Outpatient Surgery Centers
    • Hospitals
      • Private Hospitals
      • Public Hospitals
    • Specialty Clinics
      • Oncology Clinics
      • Radiology Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Hologic, Inc.
  • Becton Dickinson and Company
  • General Electric Company
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Cook Medical, Inc.
  • Merit Medical Systems, Inc.
  • Cardinal Health, Inc.
  • Medtronic plc

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Breast Biopsy Market, by Technology
8.1. Introduction
8.2. Core Needle Biopsy Devices
8.2.1. Automated Core Needle Biopsy Devices
8.2.2. Semi-Automated Core Needle Biopsy Devices
8.3. Fine Needle Aspiration Needles
8.3.1. Echo Enhanced FNA Needles
8.3.2. Standard FNA Needles
8.4. Vacuum-Assisted Systems
8.4.1. Handheld Vacuum-Assisted
8.4.2. Table Configured Vacuum-Assisted
9. Breast Biopsy Market, by Procedure Type
9.1. Introduction
9.2. MRI Guided
9.2.1. Closed Bore
9.2.2. Open Bore
9.3. Palpation Guided
9.3.1. Freehand Palpation
9.3.2. Grid Guided
9.4. Stereotactic
9.4.1. Prone Stereotactic
9.4.2. Upright Stereotactic
9.5. Ultrasound Guided
9.5.1. 2D Ultrasound Guided
9.5.2. 3D Ultrasound Guided
10. Breast Biopsy Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.2.1. Diagnostic Centers
10.2.2. Outpatient Surgery Centers
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Specialty Clinics
10.4.1. Oncology Clinics
10.4.2. Radiology Clinics
11. Americas Breast Biopsy Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Breast Biopsy Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Breast Biopsy Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Hologic, Inc.
14.3.2. Becton Dickinson and Company
14.3.3. General Electric Company
14.3.4. Siemens Healthineers AG
14.3.5. Koninklijke Philips N.V.
14.3.6. Canon Medical Systems Corporation
14.3.7. Cook Medical, Inc.
14.3.8. Merit Medical Systems, Inc.
14.3.9. Cardinal Health, Inc.
14.3.10. Medtronic plc
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. BREAST BIOPSY MARKET MULTI-CURRENCY
FIGURE 2. BREAST BIOPSY MARKET MULTI-LANGUAGE
FIGURE 3. BREAST BIOPSY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BREAST BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BREAST BIOPSY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. CANADA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. CANADA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 79. CANADA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 80. CANADA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 81. CANADA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 83. CANADA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 84. CANADA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 85. CANADA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 86. CANADA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. CANADA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 88. CANADA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. CANADA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. GERMANY BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 158. GERMANY BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 159. GERMANY BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 160. GERMANY BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 161. GERMANY BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 162. GERMANY BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 163. GERMANY BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 164. GERMANY BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 165. GERMANY BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. GERMANY BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 167. GERMANY BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. GERMANY BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 176. FRANCE BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 177. FRANCE BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 178. FRANCE BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. FRANCE BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 195. ITALY BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. ITALY BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 197. ITALY BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 198. ITALY BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 199. ITALY BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 200. ITALY BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 201. ITALY BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 202. ITALY BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 203. ITALY BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 204. ITALY BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. ITALY BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 206. ITALY BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 207. ITALY BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. SPAIN BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 210. SPAIN BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 211. SPAIN BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 212. SPAIN BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 213. SPAIN BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 214. SPAIN BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 215. SPAIN BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 216. SPAIN BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 217. SPAIN BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. SPAIN BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 219. SPAIN BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. SPAIN BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 260. DENMARK BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. DENMARK BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 262. DENMARK BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 263. DENMARK BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 264. DENMARK BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 265. DENMARK BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 266. DENMARK BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 267. DENMARK BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 268. DENMARK BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 269. DENMARK BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. DENMARK BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 271. DENMARK BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 272. DENMARK BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 286. QATAR BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. QATAR BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 288. QATAR BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 289. QATAR BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 290. QATAR BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 291. QATAR BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 292. QATAR BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 293. QATAR BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 294. QATAR BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 295. QATAR BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. QATAR BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 297. QATAR BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 298. QATAR BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 299. FINLAND BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. FINLAND BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 301. FINLAND BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 302. FINLAND BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 303. FINLAND BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 304. FINLAND BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 305. FINLAND BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 306. FINLAND BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 307. FINLAND BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 308. FINLAND BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. FINLAND BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 310. FINLAND BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 311. FINLAND BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 312. SWEDEN BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. SWEDEN BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 314. SWEDEN BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 315. SWEDEN BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 316. SWEDEN BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 317. SWEDEN BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 325. NIGERIA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 326. NIGERIA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 327. NIGERIA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 328. NIGERIA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 329. NIGERIA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 338. EGYPT BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 339. EGYPT BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2030 (USD MILLION)
TABLE 340. EGYPT BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2030 (USD MILLION)
TABLE 341. EGYPT BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 342. EGYPT BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 343. EGYPT BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2030 (USD MILLION)
TABLE 344. EGYPT BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2030 (USD MILLION)
TABLE 345. EGYPT BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2030 (USD MILLION)
TABLE 346. EGYPT BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2030 (USD MILLION)
TABLE 347. EGYPT BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 348. EGYPT BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 349.

Companies Mentioned

The companies profiled in this Breast Biopsy market report include:
  • Hologic, Inc.
  • Becton Dickinson and Company
  • General Electric Company
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Cook Medical, Inc.
  • Merit Medical Systems, Inc.
  • Cardinal Health, Inc.
  • Medtronic plc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.87 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Breast Biopsy Device Market by Product Type, Technique, End User, Application - Global Forecast to 2030 - Product Image

Breast Biopsy Device Market by Product Type, Technique, End User, Application - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report By Technology, By End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report By Technology, By End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2025-2033 - Product Image

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2025-2033

  • Report
  • 141 Pages
  • Global
From
Smart Biopsy Devices Market by Product Type, Application, Guidance Technology, End User, Component - Global Forecast to 2030 - Product Image

Smart Biopsy Devices Market by Product Type, Application, Guidance Technology, End User, Component - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Breast Biopsy Market Report 2025 - Product Image

Breast Biopsy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.